EDGAR Filing Documents for 0001193125-23-219080

Form CORRESP - Correspondence:

SEC Accession No. 0001193125-23-219080

Filing Date

2023-08-23

Accepted

2023-08-23 15:48:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	9185
	Complete submission text file	0001193125-23-219080.txt		10118

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations